Metformin keeps CD8 T cells active and moving in NASH-HCC immunotherapy.

J Hepatol

Centro de Investigación Médica Aplicada (CIMA), Universidad de Navarra, Pamplona, Spain; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain; IdiSNA, Instituto de Investigación Sanitaria de Navarra, Pamplona, Spain. Electronic address:

Published: September 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jhep.2022.05.038DOI Listing

Publication Analysis

Top Keywords

metformin cd8
4
cd8 cells
4
cells active
4
active moving
4
moving nash-hcc
4
nash-hcc immunotherapy
4
metformin
1
cells
1
active
1
moving
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!